News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
345,703 Results
Type
Article (21084)
Company Profile (141)
Press Release (324464)
Multimedia
Podcasts (112)
Webinars (17)
Section
Business (105925)
Career Advice (891)
Deals (18668)
Drug Delivery (110)
Drug Development (51061)
Employer Resources (80)
FDA (7853)
Job Trends (7825)
News (186974)
Policy (17478)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (739)
Accelerated approval (19)
Adcomms (23)
Allergies (82)
Alliances (27971)
ALS (90)
Alzheimer's disease (790)
Antibody-drug conjugate (ADC) (207)
Approvals (8030)
Artificial intelligence (281)
Autoimmune disease (79)
Automation (15)
Bankruptcy (178)
Best Places to Work (5554)
BIOSECURE Act (14)
Biosimilars (170)
Biotechnology (60)
Bladder cancer (74)
Brain cancer (34)
Breast cancer (263)
Cancer (2308)
Cardiovascular disease (239)
Career advice (740)
Career pathing (24)
CAR-T (110)
CDC (14)
Cell therapy (287)
Cervical cancer (11)
Clinical research (44814)
Collaboration (1007)
Company closure (1)
Compensation (371)
Complete response letters (52)
COVID-19 (1155)
CRISPR (49)
C-suite (532)
Cystic fibrosis (88)
Data (3292)
Decentralized trials (2)
Denatured (27)
Depression (83)
Diabetes (249)
Diagnostics (1890)
Digital health (15)
Diversity (9)
Diversity, equity & inclusion (22)
Drug discovery (170)
Drug pricing (200)
Drug shortages (33)
Duchenne muscular dystrophy (137)
Earnings (40900)
Editorial (46)
Employer branding (10)
Employer resources (78)
Events (50918)
Executive appointments (618)
FDA (9427)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (3)
Frontotemporal dementia (5)
Funding (650)
Gene editing (90)
Generative AI (31)
Gene therapy (268)
GLP-1 (823)
Government (2018)
Grass and pollen (4)
Guidances (205)
Healthcare (5919)
HIV (28)
Huntington's disease (24)
IgA nephropathy (60)
Immunology and inflammation (168)
Immuno-oncology (35)
Indications (68)
Infectious disease (1288)
Inflammatory bowel disease (118)
Inflation Reduction Act (12)
Influenza (46)
Intellectual property (136)
Interviews (118)
IPO (7428)
IRA (53)
Job creations (2442)
Job search strategy (653)
JPM (52)
Kidney cancer (10)
Labor market (61)
Layoffs (343)
Leadership (27)
Legal (4155)
Liver cancer (37)
Longevity (8)
Lung cancer (333)
Lymphoma (207)
Machine learning (21)
Management (31)
Manufacturing (524)
MASH (104)
Medical device (2002)
Medtech (2010)
Mergers & acquisitions (11767)
Metabolic disorders (882)
Multiple sclerosis (98)
NASH (20)
Neurodegenerative disease (160)
Neuropsychiatric disorders (71)
Neuroscience (1513)
Neurotech (1)
NextGen: Class of 2026 (2363)
Non-profit (915)
Now hiring (45)
Obesity (514)
Opinion (232)
Ovarian cancer (66)
Pain (146)
Pancreatic cancer (95)
Parkinson's disease (155)
Partnered (18)
Patents (278)
Patient recruitment (243)
Peanut (19)
People (34477)
Pharmaceutical (76)
Pharmacy benefit managers (33)
Phase 1 (14119)
Phase 2 (18901)
Phase 3 (15198)
Pipeline (2876)
Policy (235)
Postmarket research (1619)
Preclinical (4935)
Press Release (29)
Prostate cancer (131)
Psychedelics (27)
Radiopharmaceuticals (181)
Rare diseases (523)
Real estate (3204)
Recruiting (33)
Regulatory (13761)
Reports (25)
Research institute (835)
Resumes & cover letters (140)
Rett syndrome (6)
RNA editing (12)
RSV (43)
Schizophrenia (118)
Series A (119)
Series B (82)
Service/supplier (7)
Sickle cell disease (65)
Special edition (21)
Spinal muscular atrophy (119)
Sponsored (18)
Startups (2040)
State (2)
Stomach cancer (12)
Supply chain (76)
Tariffs (94)
The Weekly (83)
Vaccines (403)
Venture capital (68)
Weight loss (376)
Women's health (40)
Worklife (9)
Date
Last 7 days (297)
Last 30 days (1006)
Last 365 days (15236)
2026 (1465)
2025 (15479)
2024 (17668)
2023 (19639)
2022 (25866)
2021 (26641)
2020 (24871)
2019 (20058)
2018 (15588)
2017 (17253)
2016 (16202)
2015 (18803)
2014 (14789)
2013 (12554)
2012 (13485)
2011 (13818)
2010 (12738)
Location
Africa (414)
Alabama (41)
Alaska (1)
Arizona (92)
Arkansas (8)
Asia (25923)
Australia (3333)
California (4786)
Canada (1815)
China (744)
Colorado (196)
Connecticut (195)
Delaware (180)
Europe (53477)
Florida (831)
Georgia (97)
Hawaii (2)
Idaho (18)
Illinois (441)
India (51)
Indiana (293)
Iowa (5)
Japan (321)
Kansas (83)
Kentucky (29)
Louisiana (7)
Maine (4)
Maryland (595)
Massachusetts (3845)
Michigan (68)
Minnesota (241)
Mississippi (3)
Missouri (42)
Montana (12)
Nebraska (14)
Nevada (35)
New Hampshire (10)
New Jersey (1851)
New Mexico (21)
New York (1311)
North Carolina (793)
North Dakota (2)
Northern California (2239)
Ohio (129)
Oklahoma (8)
Oregon (23)
Pennsylvania (1058)
Puerto Rico (19)
Rhode Island (27)
South America (616)
South Carolina (11)
Southern California (2027)
Tennessee (64)
Texas (652)
United States (18130)
Utah (94)
Virginia (177)
Washington D.C. (60)
Washington State (375)
West Virginia (1)
Wisconsin (49)
Wyoming (1)
345,703 Results for "aptar pharma".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Aptar Acquires Sommaplast, a Specialized Provider of Oral Dosing Pharma Packaging Solutions
December 2, 2025
·
3 min read
Press Releases
Aptar Reports Fourth Quarter and Annual 2025 Results
February 6, 2026
·
20 min read
Press Releases
Aptar’s Nasal Vaccine Delivery Solutions Featured in CastleVax Phase II Clinical Trial of an Intranasal COVID-19 Vaccine Candidate
January 14, 2026
·
4 min read
Press Releases
Aptar Announces 2026 Quarterly Conference Call Dates
January 8, 2026
·
1 min read
Press Releases
Aptar Declares Quarterly Dividend and Announces 2026 Annual Meeting Details
January 23, 2026
·
2 min read
Press Releases
Aptar Pharma Continues Global Expansion with Opening of New R&D Center in France
September 26, 2025
·
4 min read
Press Releases
Aptar Pharma’s Unidose System Delivers Enbumyst™, First U.S. FDA-Approved Intranasal Diuretic
September 18, 2025
·
2 min read
Press Releases
Aptar’s Bidose Nasal System Delivers CARDAMYST™ (etripamil), the First and Only Self-Administered FDA-Approved Nasal Spray for Paroxysmal Supraventricular Tachycardia (PSVT)
December 18, 2025
·
6 min read
Press Releases
Aptar to Present at 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026
January 6, 2026
·
1 min read
Press Releases
Aptar Reports Third Quarter 2025 Results
October 31, 2025
·
19 min read
1 of 34,571
Next
